Prenatal SSRI use is linked to reduced head growth in study

03/5/2012 | Yahoo! · DailyRx.com

Babies born to mothers who took selective serotonin reuptake inhibitors were more likely to have reduced head growth, a Dutch study found. Mothers with untreated depression were more likely to give birth to babies with overall reduced growth. Researchers also found that mothers who used SSRIs had a higher risk of preterm birth compared with mothers without depression. The findings appear in the Archives of General Psychiatry.

View Full Article in:

Yahoo! · DailyRx.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI
Health Services Researcher
AARP
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC